Large-scale long-term follow-up study of Japanese patients with non-alcoholic Fatty liver disease for the onset of hepatocellular carcinoma

Kawamura, Yusuke, Arase, Yasuji, Ikeda, Kenji, Seko, Yuya, Imai, Norihiro, Hosaka, Tetsuya, Kobayashi, Masahiro, Saitoh, Satoshi +8 more·2012·American Journal of Gastroenterology

DOI 10.1038/ajg.2011.327

Cited by (280)

Items 101–200 of 280

Epidemiology of non‐alcoholic fatty liver disease and non‐alcoholic steatohepatitis in Japan: A focused literature review
Yuichiro Eguchi, Gabriel Wong, Emma J. Lee, Omar Akhtar, Ricardo Lopes, Yoshio Sumida · 2020 · JGH Open
Confounding factors of non-invasive tests for nonalcoholic fatty liver disease
Janae Wentong Wai, Charmaine Fu, Vincent Wai‐Sun Wong · 2020 · Journal of Gastroenterology
Influence of lifestyle‐related diseases and age on the development and progression of non‐alcoholic fatty liver disease
Toshihide Shima, Kojiro Seki, Atsushi Umemura, Rie Ogawa, Ryuji Horimoto, Hirohisa Oya, Rei Sendo, Masayuki Mizuno, Takeshi Okanoue · 2014 · Hepatology Research
Long‐term outcomes of non‐alcoholic fatty liver disease and the risk factors for mortality and hepatocellular carcinoma in a Japanese population
Tomomi Kogiso, Takaomi Sagawa, Kazuhisa Kodama, Makiko Taniai, Etsuko Hashimoto, Katsutoshi Tokushige · 2020 · Journal of Gastroenterology and Hepatology
Hepatocellular Carcinoma Size: Platelets, γ-Glutamyl Transpeptidase, and Alkaline Phosphatase
Brian Irving Carr, Vito Guerra · 2013 · Oncology
Clinicopathological characteristics of non‐B non‐C hepatocellular carcinoma without past hepatitis B virus infection
Takefumi Kimura, Akira Kobayashi, Naoki Tanaka, Kenji Sano, Michiharu Komatsu, Naoyuki Fujimori, Tomoo Yamazaki, Soichiro Shibata, Yūki Ichikawa, Satoru Joshita et al. · 2016 · Hepatology Research
Surveillance of Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease
Yoshio Sumida, Masashi Yoneda, Yuya Seko, Hiroshi Ishiba, Tasuku Hara, Hidenori Toyoda, Satoshi Yasuda, Takashi Kumada, Hideki Hayashi, Takashi Kobayashi et al. · 2020 · Diagnostics
Non-alcoholic fatty liver disease in adults 2021: A clinical practice guideline of the Italian Association for the Study of the Liver (AISF), the Italian Society of Diabetology (SID) and the Italian Society of Obesity (SIO)
Giulio Marchesini, Elisabetta Bugianesi, Patrizia Burra, Fabio Marra, Luca Miele, Anna Alisi, Piero Vajro, Mario Masarone, Salvatore Petta, Marcello Persico et al. · 2021 · Nutrition Metabolism and Cardiovascular Diseases
The mediterranean diet, hepatic steatosis and nonalcoholic fatty liver disease
Nicolás Velasco, Álvaro Contreras, Bruno Grassi · 2014 · Current Opinion in Clinical Nutrition & Metabolic Care
Clinical Implications of Thrombocytopenia for the Cirrhotic Patient
Samuel Harold Sigal, Zachary Sherman, Arun B. Jesudian · 2020 · Hepatic Medicine Evidence and Research
Hepatocellular Carcinoma Due to Nonalcoholic Fatty Liver Disease: Current Concepts and Future Challenges
Muhammad Imran Ahmad, Muhammad Umair Khan, Sudha Kodali, Akshay Shetty, Suzanne M. Bell, David W. Victor · 2022 · Journal of Hepatocellular Carcinoma
Serum albumin level is a notable profiling factor for non‐ B , non‐ C hepatitis virus‐related hepatocellular carcinoma: A data‐mining analysis
Shingo Yamada, Atsushi Kawaguchi, Takumi Kawaguchi, Nobuyoshi Fukushima, Ryoko Kuromatsu, Shuji Sumie, Akio Takata, Masahito Nakano, Manabu Satani, Tatsuyuki Tonan et al. · 2013 · Hepatology Research
Incidence of hepatocellular carcinoma in nonalcoholic fatty liver disease without cirrhosis or advanced liver fibrosis
Behari, Jaideep, Gougol, Amir, Wang, Renwei, Luu, Hung N., Paragomi, Pedram, Yu, Yi-Chuan, Molinari, Michele, Chopra, Kapil, Malik, Shahid M., Geller, David et al. · 2023 · Hepatology Communications
Hepatocellular carcinoma is the most common liver-related complication in patients with histopathologically-confirmed NAFLD in Japan
Norio Akuta, Yusuke Kawamura, Yasuji Arase, Satoshi Saitoh, Shunichiro Fujiyama, Hitomi Sezaki, Tetsuya Hosaka, Masahiro Kobayashi, Mariko Kobayashi, Yoshiyuki Suzuki et al. · 2018 · BMC Gastroenterology
Detection of DNA damage response in nonalcoholic fatty liver disease via p53-binding protein 1 nuclear expression
Yuko Akazawa, Ryoma Nakashima, Katsuya Matsuda, Koji Okamaoto, Ran Hirano, Hiroko Kawasaki, Satoshi Miuma, Hisamitsu Miyaaki, Harmeet Malhi, Seigo Abiru et al. · 2019 · Modern Pathology
The Patient Perspectives on Future Therapeutic Options in NASH and Patient Needs
Nigel S. Cook, Andreas Geier, Andreas Schmid, Gideon Morris Hirschfield, Achim Kautz, Jörn Markus Schattenberg, Maria‐Magdalena Balp · 2019 · Frontiers in Medicine
Attenuated effect of PNPLA3 on hepatic fibrosis by HSD17B13 in Japanese patients with non‐alcoholic fatty liver disease
Yuya Seko, Kanji Yamaguchi, Nozomi Tochiki, Kota Yano, Aya Takahashi, Shinya Okishio, Seita Kataoka, Keiichiro Okuda, Atsushi Umemura, Michihisa Moriguchi et al. · 2020 · Liver International
Thrombocytopenia in Relation to Tumor Size in Patients with Hepatocellular Carcinoma
Brian Irving Carr, Vito Guerra, Petr Pančoška · 2012 · Oncology
Non-alcoholic fatty liver disease in adults 2021: A clinical practice guideline of the Italian Association for the Study of the Liver (AISF), the Italian Society of Diabetology (SID) and the Italian Society of Obesity (SIO)
Giulio Marchesini, Elisabetta Bugianesi, Patrizia Burra, Fabio Marra, Luca Miele, Anna Alisi, Piero Vajro, Mario Masarone, Salvatore Petta, Marcello Persico et al. · 2021 · Digestive and Liver Disease
Relationships between Genetic Variations of PNPLA3, TM6SF2 and Histological Features of Nonalcoholic Fatty Liver Disease in Japan
Norio Akuta, Yusuke Kawamura, Yasuji Arase, Fumitaka Suzuki, Hitomi Sezaki, Tetsuya Hosaka, Masahiro Kobayashi, Mariko Kobayashi, Satoshi Saitoh, Yoshiyuki Suzuki et al. · 2015 · Gut and Liver
Aspartate aminotransferase to platelet ratio index as a prospective predictor of hepatocellular carcinoma risk in patients with chronic hepatitis B virus infection
Hie‐Won Hann, Shaogui Wan, Yinzhi Lai, Richard S. Hann, Ronald E. Myers, Fenil Patel, Kejin Zhang, Zhong Ye, Chun Wang, Hushan Yang · 2014 · Journal of Gastroenterology and Hepatology
Epidemiology and Etiologic Associations of Non-alcoholic Fatty Liver Disease and Associated HCC
Ken Liu, Geoffrey William McCaughan · 2018 · Advances in experimental medicine and biology
Hepatocellular carcinoma in non-alcohol fatty liver disease – changing trends and specific challenges
Aleksandra Berkan‐Kawińska, Anna Piekarska · 2019 · Current Medical Research and Opinion
Diabetes Mellitus and Liver Cancer Risk: An Evaluation Based on a Systematic Review of Epidemiologic Evidence among the Japanese Population
Keitaro Tanaka, I. Tsuji, A. Tamakoshi, K. Matsuo, K. Wakai, C. NAGATA, T. Mizoue, M. Inoue, S. Tsugane, Shizuka Sasazuki et al. · 2014 · Japanese Journal of Clinical Oncology
CARDIAL-MS (CArdio-Renal-DIAbetes-Liver-Metabolic Syndrome): a new proposition for an integrated multisystem metabolic disease
Amélio F. Godoy‐Matos, Cynthia Melissa Valério, Wellington Santana da Silva Júnior, João Marcello de Araújo Neto, Andrei Carvalho Sposito, José Hermógenes Rocco Suassuna · 2025 · Diabetology & Metabolic Syndrome
Surveillance and diagnosis of hepatocellular carcinoma: A systematic review
Sonia Pascual, Cayetano Miralles, Juan Matías Bernabé, Javier Irurzun, Mariana Cecilia Planells · 2019 · World Journal of Clinical Cases
Predictors of malignancies and overall mortality in J apanese patients with biopsy‐proven non‐alcoholic fatty liver disease
Yuya Seko, Yoshio Sumida, Saiyu Tanaka, Hiroyoshi Taketani, Kazuyuki Kanemasa, Hiroshi Ishiba, Akira Okajima, Takeshi Nishimura, Kanji Yamaguchi, Michihisa Moriguchi et al. · 2014 · Hepatology Research
Liver Stiffness-Based Risk Prediction Model for Hepatocellular Carcinoma in Patients with Nonalcoholic Fatty Liver Disease
Jae Seung Lee, Dong Hyun Sinn, Soo Young Park, Hye Jung Shin, Hye Won Lee, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Joo Hyun Oh et al. · 2021 · Cancers
Chronic liver diseases and the potential use of S-adenosyl-l-methionine as a hepatoprotector
Silvia I. Mora, Jonathan García-Román, Iván Gómez-Ñañez, Rebeca García‐Román · 2018 · European Journal of Gastroenterology & Hepatology
Updated S2k clinical practice guideline on non-alcoholic fatty liver disease (NAFLD) issued by the German society of gastroenterology, digestive and metabolic diseases (DGVS)–April 2022–AWMF Registration No.: 021–025
Authors, Collaborators: · 2022 · Zeitschrift für Gastroenterologie
Age-dependent differences in FIB-4 predictions of fibrosis in patients with MASLD referred from primary care
Shuen Sung, Mustafa Al‐Karaghouli, Matthew Tam, Yu Jun Wong, Saumya Jayakumar, Tracy Davyduke, Mang M. Ma, Juan G. Abraldeṣ · 2024 · Hepatology Communications
Epidemiology, Pathogenesis, and Diagnostic Strategy of Diabetic Liver Disease in Japan
Yoshio Sumida, Toshihide Shima, Yasuhide Mitsumoto, Takafumi Katayama, Atsushi Umemura, Kanji Yamaguchi, Yoshito Itoh, Masashi Yoneda, Takeshi Okanoue · 2020 · International Journal of Molecular Sciences
Comorbidities and healthcare costs and resource use of patients with nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) in the Japan medical data vision database
Shuji Terai, Amy Buchanan-Hughes, Alvin Ng, I‐Heng Lee, Ken Hasegawa · 2021 · Journal of Gastroenterology
Hepatocellular carcinoma in non-alcoholic steatohepatitis without cirrhosis
Cristiane Valle Tovo, Ângelo Zambam de Mattos, Gabriela Perdomo Coral, Giovana Dal Pozzo SARTORI, Lívia Villela Nogueira, Gustavo Tovo Both, Cristiane Alves Villela‐Nogueira, Ângelo Alves de Mattos · 2023 · World Journal of Gastroenterology
Significance of non‐alcoholic fatty liver disease in Crohn's disease: A retrospective cohort study
Shintaro Sagami, Yoshitaka Ueno, Shinji Tanaka, Akira Fujita, Ryohei Hayashi, Shiro Oka, Hideyuki Hyogo, Kazuaki Chayama · 2016 · Hepatology Research
Comparison of Hepatocellular Carcinoma in Patients with Cryptogenic Versus Hepatitis B Etiology: A Study of 1079 Cases Over 3 Decades
Zhong Hong Liew, George Boon‐Bee Goh, Ying Hao, Jason Pik-Eu Chang, Chee‐Kiat Tan · 2018 · Digestive Diseases and Sciences
Hepatocellular carcinoma as a leading cause of cancer-related deaths in Japanese type 2 diabetes mellitus patients
Toshihide Shima, Hirofumi Uto, Kohjiro Ueki, Yutaka Kohgo, Kohichiroh Yasui, Naoto Nakamura, Tatsuaki Nakatou, Toshinari Takamura, Sumio Kawata, Kazuo Notsumata et al. · 2018 · Journal of Gastroenterology
Clinical features of hepatocellular carcinoma in nonalcoholic fatty liver disease patients without advanced fibrosis
Kazuhisa Kodama, Takumi Kawaguchi, Hideyuki Hyogo, Tomoaki Nakajima, Masafumi Ono, Masataka Seike, Hirokazu Takahashi, Yuichi Nozaki, Miwa Kawanaka, Saiyu Tanaka et al. · 2019 · Journal of Gastroenterology and Hepatology
Statin can reduce the risk of hepatocellular carcinoma among patients with nonalcoholic fatty liver disease: a systematic review and meta-analysis
Zhang, Jie, Fu, Shifeng, Liu, Deliang, Wang, Yongjun, Tan, Yuyong · 2023 · European Journal of Gastroenterology & Hepatology
Small Hepatocellular Carcinomas and Thrombocytopenia
Brian Irving Carr, Vito Guerra, Massimo De Giorgio, Stefano FAGIUOLI, Petr Pančoška · 2012 · Oncology
Hepatocellular carcinoma and other complications of non‐alcoholic fatty liver disease and non‐alcoholic steatohepatitis in Japan: A structured review of published works
Yuichiro Eguchi, Gabriel Wong, I‐Heng Lee, Omar Akhtar, Ricardo Lopes, Yoshio Sumida · 2020 · Hepatology Research
Risk factors and diagnostic biomarkers for nonalcoholic fatty liver disease-associated hepatocellular carcinoma: Current evidence and future perspectives
M. Ueno, H. Takeda, Atsushi Takai, H. Seno · 2022 · World Journal of Gastroenterology
A gathering storm
Nitin Kapoor, Jennifer Audsley, Priscilla Rupali, Joe J Sasadeusz, Thomas Vizhalil Paul, Nihal Thomas, Sharon R. Lewin · 2019 · AIDS
Emerging risk factors for nonalcoholic fatty liver disease associated hepatocellular carcinoma
Jihane N. Benhammou, Jonathan Lin, Shehnaz K. Hussain, Mohamed M. El-Kabany · 2020 · Hepatoma Research
Persistent Hepatic Inflammation Plays a Role in Hepatocellular Carcinoma After Sustained Virological Response in Patients with HCV Infection
Kazushige Nirei, Tatsuo Kanda, Hitomi Nakamura, Shunichi Matsuoka, Tadatoshi Takayama, Masahiko Sugitani, Mitsuhiko Moriyama · 2018 · International Journal of Medical Sciences
FIB-4 index-based surveillance for advanced liver fibrosis in diabetes patients
Nozomi Kawata, Hirokazu Takahashi, Shinji Iwane, Kanako Inoue, Motoyasu Kojima, Michiko Kohno, Kenichi Tanaka, Hitoe Mori, Hiroshi Isoda, Satoshi Oeda et al. · 2020 · Diabetology International
Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: new trends and role of ultrasonography
Toshifumi Tada, Takashi Nishimura, Masahiro Yoshida, Hiroko Iijima · 2020 · Journal of Medical Ultrasonics
Liver Renewal: Detecting Misrepair and Optimizing Regeneration
Mariana Verdelho Machado, Anna Mae Diehl · 2014 · Mayo Clinic Proceedings
Metabolic Dysfunction-Associated Steatotic Liver Disease: A Silent Driver of Cardiovascular Risk and a New Target for Intervention
Giovanna Gallo, Gabriele Nalli, Francesco Baratta, Giovambattista Desideri, Carmine Savoia · 2025 · International Journal of Molecular Sciences
Wisteria floribunda agglutinin‐positive Mac‐2 binding protein predicts the development of hepatocellular carcinoma in patients with non‐alcoholic fatty liver disease
Miwa Kawanaka, Yasuyuki Tomiyama, Hideyuki Hyogo, Masahiko Koda, Toshihide Shima, Hiroshi Tobita, Akira Hiramatsu, Ken Nishino, Toshiaki Okamoto, Shuichi Sato et al. · 2018 · Hepatology Research
Magnitude of Nonalcoholic Fatty Liver Disease: Eastern Perspective
Becky Ching-Yeung Yu, Deborah Kwok, Vincent Wai‐Sun Wong · 2019 · Journal of Clinical and Experimental Hepatology
Nonalcoholic fatty liver disease: Fibrosis portends a worse prognosis
Dawn McDowell Torres, Stephen A. Harrison · 2015 · Hepatology
Not routine screening, but vigilance for chronic liver disease in patients with type 2 diabetes
Vincent Wai‐Sun Wong, Naga Chalasani · 2016 · Journal of Hepatology
Weighing the benefits of hepatocellular carcinoma surveillance against potential harms
Daniel Geh, Fahd A. Rana, Helen Louise Reeves · 2019 · Journal of Hepatocellular Carcinoma
Characterizing the mechanism behind the progression of NAFLD to hepatocellular carcinoma
P. Nahon, M. Allaire, J. Nault, V. Paradis · 2020 · Hepatic Oncology
Liver function indicators and risk of hepatocellular carcinoma: a bidirectional mendelian randomization study
Shanshan Qin, Jing Wang, Haiqing Yuan, Jingzhen He, Shoujing Luan, Yan Deng · 2024 · Frontiers in Genetics
Natural history of nonalcoholic steatohepatitis/nonalcoholic fatty liver disease‐hepatocellular carcinoma: Magnitude of the problem from a hepatology clinic perspective
Delia D’Avola, Ismaïl Labgaa, Augusto Villanueva · 2016 · Clinical Liver Disease
Non-alcoholic fatty liver disease in adults 2021: A clinical practice guideline of the Italian Association for the Study of the Liver (AISF), the Italian Society of Diabetology (SID) and the Italian Society of Obesity (SIO)
Associazione Italiana per lo Studio del Fegato (AISF), Società Italiana di Diabetologia (SID) and Società Italiana dell’Obesità (SIO) · 2021 · Eating and Weight Disorders - Studies on Anorexia Bulimia and Obesity
Noninvasive Assessment of Advanced Fibrosis Based on Hepatic Volume in Patients with Nonalcoholic Fatty Liver Disease
Tatsuya Hayashi, Satoshi Saitoh, Kei Fukuzawa, Yoshinori Tsuji, Junji Takahashi, Yusuke Kawamura, Norio Akuta, Masahiro Kobayashi, Kenji Ikeda, Takeshi Fujii et al. · 2017 · Gut and Liver
The Current View of Nonalcoholic Fatty Liver Disease-Related Hepatocellular Carcinoma
Tomomi Kogiso, Katsutoshi Tokushige · 2021 · Cancers
Accumulation of Genetic and Epigenetic Alterations in the Background Liver and Emergence of Hepatocellular Carcinoma in Patients with Non-Alcoholic Fatty Liver Disease
Satoru Hagiwara, Naoshi Nishida, Kazuomi Ueshima, Yasunori Minami, Yoriaki Komeda, Tomoko Aoki, Masahiro Takita, Masahiro Morita, Hirokazu Chishina, Akihiro Yoshida et al. · 2021 · Cells
Impact of NAFLD on clinical outcomes in hepatocellular carcinoma treated with sorafenib: an international cohort study
Jessica A. Howell, Amit Samani, Binish Mannan, Saur Hajiev, Leila Motedayеn Aval, Rebecca Abdelmalak, Vincent Channing Tam, Dominik Bettinger, Robert Thimme, Tamar Hamosh Taddei et al. · 2022 · Therapeutic Advances in Gastroenterology
Role of MicroRNAs in Pathophysiology of Non-alcoholic Fatty Liver Disease and Non-alcoholic Steatohepatitis
Farzaneh Iravani, Neda Hosseini, Majid Mojarrad · 2018 · Middle East Journal of Digestive Diseases
Advances and challenges in the management of advanced fibrosis in nonalcoholic steatohepatitis
Mehmet Sayıner, Brian P Lam, Pegah Golabi, Zobair M. Younossi · 2018 · Therapeutic Advances in Gastroenterology
Metabolic factors affecting hepatocellular carcinoma in steatohepatitis
Ali Zarrinpar, Claire M. Faltermeier, Vatche Garen Agopian, Bita V. Naini, Michael P. Harlander‐Locke, Fady M. Kaldas, Douglas G. Farmer, Ronald W. Busuttil · 2018 · Liver International
Non-invasive predictors of prognosis of Asian patients with histopathologically-confirmed lean nonalcoholic fatty liver disease
Soichi Iritani, Norio Akuta, Yusuke Kawamura, Akira Kajiwara, Kayoko Kasuya, Shunichiro Fujiyama, Hitomi Sezaki, Tetsuya Hosaka, Masahiro Kobayashi, Mariko Kobayashi et al. · 2020 · BMC Gastroenterology
Agile 3+ and Agile 4, noninvasive tests for liver fibrosis, are excellent formulae to predict liver‐related events in nonalcoholic fatty liver disease
Kouichi Miura, Hideki Hayashi, Yoshihiro Kamada, Hideki Fujii, Hirokazu Takahashi, Satoshi Oeda, Michihiro Iwaki, Takumi Kawaguchi, Eiichi Tomita, Masato Yoneda et al. · 2023 · Hepatology Research
Noninvasive fibrosis marker can predict recurrence of hepatocellular carcinoma after radiofrequency ablation
Jeong Han Kim, HyunAh Chung, Young Hwang, Hong Seok Choi, Soon Young Ko, Won Hyeok Choe, So Young Kwon · 2016 · Saudi Journal of Gastroenterology
An Overview of NAFLD/NASH in Japan
Soo Ryang Kim, Ke Ih Kim · 2016 · YAKUGAKU ZASSHI
Correlation analysis of metabolic characteristics and the risk of metabolic-associated fatty liver disease - related hepatocellular carcinoma
Xuancheng Xie, Mengyao Zheng, Weibo Guo, Ying Zhou, Zhao Xiang, Yuting Li, Jinhui Yang · 2022 · Scientific Reports
Modifiable Risk Factors for Hepatocellular Carcinoma in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease: A Meta-Analysis
Shiyu Xiao, Ya Liu, Xiliang Fu, Tong Chen, Wenhui Xie · 2024 · The American Journal of Medicine
Converging Pathways between Metabolic Dysfunction–Associated Steatotic Liver Disease (MASLD) and Diabetes in Children
Maria Felicia Faienza, Ilaria Farella, Mohamad Khalil, Piero Portincasa · 2024 · International Journal of Molecular Sciences
Ultrasonography screening for hepatocellular carcinoma in Japanese patients with diabetes mellitus
Atsushi Hiraoka, Marie Ochi, Rie Matsuda, Toshihiko Aibiki, Tomonari Okudaira, Tomoe Kawamura, Hiroka Yamago, Hiromasa Nakahara, Yoshifumi Suga, Nobuaki Azemoto et al. · 2015 · Journal of Diabetes
Clinical Characteristics of Patients with Cryptogenic Hepatocellular Carcinoma in a Hepatitis B Virus-Endemic Area
Heewon A. Kwak, Joong‐Won Park, Young Hwan Koh, Ju Hee Lee, Ami Yu, Byung‐Ho Nam · 2015 · Liver Cancer
Differentiation of clinical patterns and survival outcomes of hepatocellular carcinoma on hepatitis B and nonalcoholic fatty liver disease
Bou-Zenn Lin, Tsung‐Jung Lin, Chih‐Lin Lin, Li-Ying Liao, Ting‐An Chang, Buo-Jia Lu, Kuan-Yang Chen · 2021 · Journal of the Chinese Medical Association
Association of metabolic traits with occurrence of nonalcoholic fatty liver disease-related hepatocellular carcinoma
Jin Chen, Shu Song, Xiangsu Li, Dongxue Bian, Xudong Wu · 2021 · Saudi Journal of Gastroenterology
Nonalcoholic hepatic steatosis: a silent disease
Asdrúbal Aguilera‐Méndez · 2019 · PubMed
Effects of alcohol consumption on multiple hepatocarcinogenesis in patients with fatty liver disease
Yorinari Ochiai, Yusuke Kawamura, Masahiro Kobayashi, Junichi Shindoh, Yuta Kobayashi, Satoshi Okubo, Nozomu Muraishi, Akira Kajiwara, Soichi Iritani, Shunichiro Fujiyama et al. · 2020 · Hepatology Research
Long-Term Outcomes of Nonalcoholic Fatty Liver Disease
Min‐Sun Kwak, Donghee Kim · 2015 · Current Hepatology Reports
Use of noninvasive markers to predict advanced fibrosis/cirrhosis in severe obesity
Roberto de Cleva, Livio Fiolo Duarte, Milton Roberto Furst Crenitte, Claudia Pinto Marques de Oliveira, Dênis Pajecki, Marco Aurélio Santo · 2015 · Surgery for Obesity and Related Diseases
The FIB-4 index is a significant prognostic factor in patients with non-B non-C hepatocellular carcinoma after curative surgery
Yukiyasu Okamura, Ryo Ashida, Yusuke Yamamoto, Takaaki Ito, Teiichi Sugiura, Emima Bekku, Takeshi Aramaki, Katsuhiko Uesaka · 2016 · Langenbeck s Archives of Surgery
Multicenter, multivendor phantom study to validate proton density fat fraction and T2* values calculated using vendor-provided 6-point DIXON methods
Tatsuya Hayashi, Kei Fukuzawa, Hidekazu Yamazaki, Takashi Konno, Tosiaki Miyati, J. Kotoku, Hiroshi Oba, Hiroshi Kondo, Keiko Toyoda, Satoshi Saitoh · 2018 · Clinical Imaging
Artificial Intelligence and Image Analysis-Assisted Diagnosis for Fibrosis Stage of Metabolic Dysfunction-Associated Steatotic Liver Disease Using Ultrasonography: A Pilot Study
Itsuki Fujii, Naoki Matsumoto, Masahiro Ogawa, Aya Konishi, Masahiro Kaneko, Yukinobu Watanabe, Ryota Masuzaki, Hirofumi Kogure, Norihiro Koizumi, Masahiko Sugitani · 2024 · Diagnostics
Effect of coffee and green tea consumption on liver enzyme and metabolic syndrome in Korean
Eun Kyoung Kim, Dae Won Jun, Eun-Chul Jang, Sang Heum Kim, Ho-Soon Choi · 2012 · Journal of the Korea Academia-Industrial cooperation Society
Non-alcoholic fatty liver disease-related hepatocellular carcinoma: a sleeping tiger in the Asia Pacific
Roslyn Vongsuvanh, David van der Poorten, Jacob George · 2013 · Hepatology International
Relation between antibody to hepatitis B core antigen and survival after curative therapy for non-B non-C hepatocellular carcinoma.
Hiroki Nishikawa, Yukio Osaki, Akira Arimoto, Ryuichi Kita, Tōru Kimura · 2013 · PubMed
Surveillance for Hepatocellular Carcinoma
Jorge A. Marrero · 2020 · Clinics in Liver Disease
Diagnostics and omics technologies for the detection and prediction of metabolic dysfunction-associated steatotic liver disease-related malignancies
Tian Lan, Frank Tacke · 2024 · Metabolism
Pulmonary hypertension is associated with an increased incidence of NAFLD: A retrospective cohort study of 18,910 patients
Markus Sebastian Jördens, Mark Luedde, Christoph Roderburg, Münevver Demir, Tom Luedde, Karel Kostev, Sven Heiko Loosen · 2021 · Journal of Internal Medicine
Epidemiology and Risk Factors of Hepatocellular Carcinoma
Hashem B. El‐Serag, Maya Balakrishnan, Yamini Natarajan · 2024 · Wiley eBooks
A new insight: crosstalk between neutrophil extracellular traps and the gut-liver axis for nonalcoholic fatty liver disease
Jinping Yin, Yanli Zhu, Rongrong Liu, Weixin Wang, Zhicheng Wang, Jianfeng Wang · 2025 · Frontiers in Immunology
New discriminant score to predict the fibrotic stage of non-alcoholic steatohepatitis in Japan
Yusuke Kawamura, Kenji Ikeda, Yasuji Arase, Yushi Sorin, Taito Fukushima, Hideo Kunimoto, Tetsuya Hosaka, Masahiro Kobayashi, Satoshi Saitoh, Hitomi Sezaki et al. · 2015 · Hepatology International
Development of a prognostic scoring model for predicting the survival of elderly patients with hepatocellular carcinoma
Sizhe Wan, Yuan Nie, Xuan Zhu · 2020 · PeerJ
Immunotherapy for nonalcoholic fatty liver disease-related hepatocellular carcinoma: Lights and shadows
F. Costante, Carlo Airola, F. Santopaolo, A. Gasbarrini, M. Pompili, F. Ponziani · 2022 · World Journal of Gastrointestinal Oncology
Early diagnosis of hepatic inflammation in Japanese nonalcoholic fatty liver disease patients using 3D MR elastography
Yasuyuki Komiyama, Utaroh Motosugi, Shinya Maekawa, Leona Osawa, Natsuko Nakakuki, Hitomi Takada, Masaru Muraoka, Yuichiro Suzuki, Mitsuaki Sato, Shinichi Takano et al. · 2022 · Hepatology Research
Clinical features and management issues of NAFLD-related HCC: what we know so far
Nicola Pugliese, Ludovico Alfarone, Ivan Arcari, Silvia Giugliano, Tommaso Lorenzo Parigi, María Rescigno, Ana Lleò, Alessio Aghemo · 2022 · Expert Review of Gastroenterology & Hepatology
Role of sodium-glucose co-transporter-2 inhibitors in the management of nonalcoholic fatty liver disease
Anastasia Kontana, Κωνσταντίνος Τζιόμαλος · 2019 · World Journal of Gastroenterology
Simultaneous Activation of Beta‐Oxidation and De Novo Lipogenesis in MASLD ‐ HCC : A New Paradigm
Fatima Dahboul, Jihan Sun, Benjamin Buchard, Natali Abeywickrama Samarakoon, Estelle Pujos‐Guillot, Stéphanie Durand, Mélanie Pétéra, Delphine Centeno, Francesca Guerrieri, Massimiliano Cocca et al. · 2025 · Liver International
Frontiers of Collaboration between Primary Care and Specialists in the Management of Metabolic Dysfunction-Associated Steatotic Liver Disease: A Review
Koki Nagai, Kazuki Nagai, Michihiro Iwaki, Takashi Kobayashi, Asako Nogami, Masanao Oka, Satoru Saito, Masato Yoneda · 2023 · Life
Magnetic Resonance Imaging in Cirrhosis
Daniel C. Barr, Hero K. Hussain · 2014 · Topics in Magnetic Resonance Imaging